Cargando…
The Protective Mechanism of Afuresertib against Esophageal Cancer
Esophageal cancer (EC) is a common malignant tumor of the digestive system. Exploring the molecular biological mechanism of EC will help to clarify its carcinogenesis mechanism, find important molecular targets in the process of carcinogenesis, and provide new ideas for the diagnosis and treatment o...
Autores principales: | Min, Bo, Wang, Yan, Liang, Feng, Wang, Cheng-Xiang, Wang, Fan, Yang, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303141/ https://www.ncbi.nlm.nih.gov/pubmed/35872696 http://dx.doi.org/10.1155/2022/1832241 |
Ejemplares similares
-
Novel ATP‐competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells
por: Yamaji, Masayuki, et al.
Publicado: (2017) -
Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms in vitro and in vivo
por: Tang, Jian-Cai, et al.
Publicado: (2018) -
Mechanisms of esophageal cancer metastasis and treatment progress
por: Wang, Yusheng, et al.
Publicado: (2023) -
Changes in cardiac volume determined with repeated enhanced 4DCT during chemoradiotherapy for esophageal cancer
por: Wang, Xue, et al.
Publicado: (2018) -
Discovery of novel mRNA demethylase FTO inhibitors against esophageal cancer
por: Qin, Bo, et al.
Publicado: (2022)